Jay Lichter, Director, 10% Owner at ARATANA THERAPEUTICS, INC. (PETX), bought 500,000 shares at $6.00 ($3.0M) on 2013-07-02, disclosed to the SEC on 2014-02-04.
Open-market purchase of $3.0M PETX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| JANX | BUY | 2023-11-15 | $10.0M | — | Filing → |
| JANX | BUY | 2021-06-16 | $10.7M | — | Filing → |
| OTIC | SELL | 2021-03-03 | $1.7M | — | Filing → |